|
|
|
Volumn 42, Issue 1081, 2000, Pages 53-54
|
|
Alosetron (Lotronex) for treatment of irritable bowel syndrome
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALOSETRON;
CLINICAL TRIAL;
CONSTIPATION;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG ABSORPTION;
DRUG EFFECT;
DRUG EFFICACY;
DRUG EXCRETION;
DRUG MECHANISM;
FEMALE;
HUMAN;
IRRITABLE COLON;
ISCHEMIC COLITIS;
MAJOR CLINICAL STUDY;
RANDOMIZED CONTROLLED TRIAL;
SHORT SURVEY;
CARBOLINES;
COLONIC DISEASES, FUNCTIONAL;
CONSTIPATION;
DOSE-RESPONSE RELATIONSHIP, DRUG;
FEES, PHARMACEUTICAL;
HUMANS;
INTESTINAL ABSORPTION;
RANDOMIZED CONTROLLED TRIALS;
SEROTONIN ANTAGONISTS;
|
|
EID: 0034717823
PISSN: 0025732X
EISSN: None
Source Type: Journal
DOI: None Document Type: Short Survey |
|
Times cited : (6)
|
|
References (0)
|